BRCA1 and neoplasm: By stimulating ATR–CHK1 signalling, activation of the G2/M and S/G2 cell-cycle checkpoints, at least in part, overcomes the lethal block caused by Brca1 deficiency through suppression of the mitotic catastrophe and promotes tumour initiation (Fig. 8g).